Reuters logo
BRIEF-Boehringer, Dicerna collaborate to develop novel treatments for chronic liver diseases including nonalcoholic steatohepatitis
November 2, 2017 / 10:47 AM / a month ago

BRIEF-Boehringer, Dicerna collaborate to develop novel treatments for chronic liver diseases including nonalcoholic steatohepatitis

Nov 2 (Reuters) - Dicerna Pharmaceuticals Inc

* Boehringer Ingelheim and Dicerna announce collaboration to develop novel treatments for chronic liver diseases including nonalcoholic steatohepatitis (NASH)

* Dicerna Pharmaceuticals Inc - ‍under terms of agreement, Dicerna may receive more than $200 million from Boehringer Ingelheim​

* Dicerna Pharmaceuticals Inc - ‍Dicerna is also eligible to receive royalties staggered up to double-digits on worldwide net sales​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below